Both in Pharmaceuticals
Biofrontera vs Citius Pharmaceuticals
Over the past year BFRI returned −12.1% and CTXR returned −62.7%; their daily moves had a correlation of 0.10.
BFRI −12.1% CTXR −62.7%Growth of $1, one year, split-adjusted
| Metric | BFRI | CTXR |
|---|---|---|
| Price | $0.9315 | $0.5631 |
| Market cap | $13.8M | $15.5M |
| Today | +5.09% | +4.07% |
| 1 month | −13.8% | +6.0% |
| 6 months | −13.8% | −19.1% |
| Year to date | +63.4% | −27.5% |
| 1 year | −12.1% | −63.7% |
| Revenue growth (YoY) | +32.9% | — |
| Gross margin | 79.9% | 67.1% |
| Net margin | −5.0% | −593.3% |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | 2.2× |
| Net cash | $47.0K | $10.6M |
| Dividend yield | — | — |
| Volatility (60d) | 75.4% | 102.9% |
| Short % of float | 0.9% | 21.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).